Tue, Jul 22, 2014, 10:35 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

ZIOPHARM Oncology, Inc. Message Board

  • rob_cos rob_cos Jan 9, 2013 5:35 PM Flag

    Ph 3 Picasso data possible Late Breaker at ASCO after PR/Conf call at time of data....


    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I think that this news or data will be leaking out and I mean soon!

      Sentiment: Strong Buy

      • 2 Replies to zahnd9898
      • Management is pushing the deadlines right up to the last moment. This shows supreme confidence on the part of management. I don't think they would jump through all these hoops to present an abstract that shows our Picasso Phase III trial failed. JMO

        Sentiment: Strong Buy

      • They really nailed the ASCO late breaking abstract with the timing of this...look at the guidelines:

        The ASCO Late-Breaking Abstracts Policy allows for the submission of Late-Breaking Abstracts only for randomized phase III trials for which no preliminary data are available at the time of the abstract submission deadline (February 5, 2013), but for which a preplanned analysis of the primary endpoint is scheduled after that date but before April 1, 2013 (deadline for the final, updated Late-Breaking Abstract). During abstract submission, you will be required to provide the date of planned analysis. The policy is not a mechanism to allow for updated data to be submitted later when preliminary data are available by the abstract submission deadline.

        Missed the normal abstract deadline by a week, and will get the analysis done a week before the second deadline.

3.24-0.03(-0.92%)Jul 22 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.